U

AnserBio

Former names: ExoProTher Medical
Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. -
Startup Seed Founded 2017 Health Tech & Life Sciences
Last Update Mar 20, 2025 · Claimed

AnserBio Business

Business models
B2B
Product stage
R&D
Employees
1-10

Sector

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Target Customer

Healthcare & Life SciencesLife SciencesPharmaceuticals

Core Technology

Materials & SubstancesNanomaterialsBiologicalsCells

Tags (7)

biotechnologymedical-technologiestherapeuticsoncologycancercell-therapynanotechnology

Geographic Markets

Global